0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Dermatology Patient Page |

Graft-vs-Host Disease FREE

Edward West Cowen, MD, MHSc
JAMA Dermatol. 2016;152(3):356. doi:10.1001/jamadermatol.2015.5659.
Text Size: A A A
Published online

Graft-vs-host disease (GVHD) occurs in some patients after bone-marrow transplantation (BMT).

Also called stem cell transplantation, BMT is a procedure in which blood stem cells are removed from a donor and inserted into a host patient to create different blood cells and a new host immune system. It is reserved for severe, life-threatening medical conditions. The most important danger of BMT is GVHD. This occurs when the transplanted cells attack normal organs in the host. Acute GVHD usually occurs within the first few months after transplantation, but chronic GVHD can occur several months or even years after BMT.

SYMPTOMS

Acute GVHD causes a red skin rash, diarrhea, and/or liver problems. Acute GVHD often starts on the palms, soles, or face, but it may spread to the entire body and can sometimes be severe enough that blistering of the skin may occur.

Chronic GVHD can cause damage to many different organs. Common problems are dry and irritated eyes, dryness and sores in the mouth, and skin rashes. Chronic GVHD of the skin can cause color changes (red, pink, purple, brown, or white), skin thinning or thickening or hardening, rashes, scaly areas, bumps, sores, or blisters. The skin may itch, feel like sunburn, or feel “tight” and “woody” like a stick.

Chronic GVHD can affect the skin anywhere on the body and also damage the hair and nails. Patients may lose their hair. The nails may become more fragile and split or break more easily. In addition, involvement of the genital skin may cause pain and scarring and interfere with sexual function.

Sclerotic chronic GVHD is a specific type of skin problem in which there is thickening, tightness, and hardening of the skin and deeper tissues. This can also make it hard to move the joints. It is more common on arms, legs, lower belly, and lower back, but it can occur anywhere. Sclerotic chronic GVHD may also cause skin sores (ulcers) to heal slowly. Ulcers are more common on the legs.

DIAGNOSIS AND TESTING

A skin biopsy may be necessary to confirm a diagnosis of chronic GVHD but is not always needed.

TREATMENT

Treatment for skin GVHD is challenging, often requiring several types of therapy, and usually involves both a dermatologist and the BMT physician. When there is skin thickening, physical therapy is important to keep the joints mobile. Topical steroid creams and other topical drugs may decrease pain and itching. Specialized wound care dressings may be helpful to heal open ulcers. Ultraviolet (UV) light (phototherapy) may also be used. In this treatment, patients are treated in a doctor’s office with a special UV light that helps to calm skin inflammation. Extracorporeal photopheresis also uses UV light to treat GVHD but is performed directly on the patient’s blood.

Box Section Ref ID

For More Information

To find this and other JAMA Dermatology Patient Pages, go to the Patient Page link on the JAMA Dermatology website at http://www.jamaderm.com.

ARTICLE INFORMATION

Section Editor: Misha Rosenbach, MD
The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call (312) 464-0776.

Conflict of Interest Disclosures: None reported.

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

8,293 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs